1,461
Views
0
CrossRef citations to date
0
Altmetric
Biomarkers

Benefits of MR-proADM-guided decision-making in the emergency department: clinical and economic evaluation in Italy, Germany, Spain, and the UK

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 826-834 | Received 12 May 2023, Accepted 12 Jun 2023, Published online: 30 Jun 2023

References

  • Kutz A, Florin J, Hausfater P, et al. Predictors for delayed emergency department care in medical patients with acute infections – an international prospective observational study. PLOS One. 2016;11(5):e0155363. doi: 10.1371/journal.pone.0155363.
  • Chmiel C, Wang M, Sidler P, et al. Implementation of a hospital-integrated general practice–a successful way to reduce the burden of inappropriate emergency-department use. Swiss Med Wkly. 2016;146:w14284. doi: 10.4414/smw.2016.14284.
  • Murtas R, Tunesi S, Andreano A, et al. Time-series cohort study to forecast emergency department visits in the city of Milan and predict high demand: a 2-day warning system. BMJ Open. 2022;12(4):e056017. doi: 10.1136/bmjopen-2021-056017.
  • Jayaprakash N, O'Sullivan R, Bey T, et al. Crowding and delivery of healthcare in emergency departments: the European perspective. West J Emerg Med. 2009;10(4):233–239.
  • Di Somma S, Paladino L, Vaughan L, et al. Overcrowding in emergency department: an international issue. Intern Emerg Med. 2015;10(2):171–175. doi: 10.1007/s11739-014-1154-8.
  • Mohiuddin S, Busby J, Savović J, et al. Patient flow within UK emergency departments: a systematic review of the use of computer simulation modelling methods. BMJ Open. 2017;7(5):e015007. doi: 10.1136/bmjopen-2016-015007.
  • Savioli G, Ceresa IF, Gri N, et al. Emergency department overcrowding: understanding the factors to find corresponding solutions. J Pers Med. 2022;12(2):279.
  • Gonzalez Del Castillo J, Wilson DC, Clemente-Callejo C, et al. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission. Crit Care. 2019;23(1):335. doi: 10.1186/s13054-019-2613-4.
  • Kenny JF, Chang BC, Hemmert KC. Factors affecting emergency department crowding. Emerg Med Clin North Am. 2020;38(3):573–587. doi: 10.1016/j.emc.2020.04.001.
  • Krochmal P, Riley TA. Increased health care costs associated with ED overcrowding. Am J Emerg Med. 1994;12(3):265–266. doi: 10.1016/0735-6757(94)90135-x.
  • Tatar D, Senol G, Anar C, et al. Markers of lower respiratory tract infections in emergency departments. Multidiscip Respir Med. 2013;8(1):20. doi: 10.1186/2049-6958-8-20.
  • Shallcross LJ, Rockenschaub P, McNulty D, et al. Diagnostic uncertainty and urinary tract infection in the emergency department: a cohort study from a UK hospital. BMC Emerg Med. 2020;20(1):40. doi: 10.1186/s12873-020-00333-y.
  • Sartelli M, Chichom-Mefire A, Labricciosa FM, et al. The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2017;12(1):29. doi: 10.1186/s13017-017-0141-6.
  • Kamath RS, Sudhakar D, Gardner JG, et al. Guidelines vs actual management of skin and soft tissue infections in the emergency department. Open Forum Infect Dis. 2018;5(1):ofx188.
  • Saeed K, Wilson DC, Bloos F, et al. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study. Crit Care. 2019;23(1):40. doi: 10.1186/s13054-019-2329-5.
  • Chen YS, Liao TY, Hsu TC, et al. Temporal trend and survival impact of infection source among patients with sepsis: a nationwide study. Crit Care Resusc. 2020;22(2):126–132. doi: 10.51893/2020.2.oa2.
  • Fleischmann-Struzek C, Mikolajetz A, Schwarzkopf D, et al. Challenges in assessing the burden of sepsis and understanding the inequalities of sepsis outcomes between national health systems: secular trends in sepsis and infection incidence and mortality in Germany. Intensive Care Med. 2018;44(11):1826–1835. doi: 10.1007/s00134-018-5377-4.
  • Paoli CJ, Reynolds MA, Sinha M, et al. Epidemiology and costs of sepsis in the United States–an analysis based on timing of diagnosis and severity level. Crit Care Med. 2018;46(12):1889–1897. doi: 10.1097/CCM.0000000000003342.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi: 10.1001/jama.2016.0287.
  • Macdonald SP, Williams JM, Shetty A, et al. Review article: sepsis in the emergency department – part 1: definitions and outcomes. Emerg Med Australas. 2017;29(6):619–625. doi: 10.1111/1742-6723.12886.
  • Yébenes JC. Early detection of sepsis: to adapt or to die. Med Clin. 2017;149(5):209–210. doi: 10.1016/j.medcle.2017.07.025.
  • Bermejo-Martin JF, Martín-Fernandez M, Almansa R. Pre-sepsis: a necessary concept to complete the SEPSIS-3 picture? J Crit Care. 2018;44:148. doi: 10.1016/j.jcrc.2017.10.041.
  • Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–1596. doi: 10.1097/01.CCM.0000217961.75225.E9.
  • Leisman DE, Goldman C, Doerfler ME, et al. Patterns and outcomes associated with timeliness of initial crystalloid resuscitation in a prospective sepsis and septic shock cohort. Crit Care Med. 2017;45(10):1596–1606. doi: 10.1097/CCM.0000000000002574.
  • Chiarella F, González-Del Castillo J, Candel FJ, et al. Key issues in the infected patient care in the emergency department. Rev Esp Quimioter. 2016;29(6):318–327.
  • Francis NA, Cals JW, Butler CC, et al. Severity assessment for lower respiratory tract infections: potential use and validity of the CRB-65 in primary care. Prim Care Respir J. 2012;21(1):65–70. doi: 10.4104/pcrj.2011.00083.
  • Zilberberg MD, Nathanson BH, Sulham K, et al. Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the United States, 2016–2018. J Am Coll Emerg Physicians Open. 2022;3(2):e12694. doi: 10.1002/emp2.12694.
  • Gonzalez del Castillo J, Clemente-Callejo C, Llopis F, et al. Midregional proadrenomedullin safely reduces hospitalization in a low severity cohort with infections in the ED: a randomized controlled multi-centre interventional pilot study. Eur J Intern Med. 2021;88:104–113. doi: 10.1016/j.ejim.2021.03.041.
  • Elke G, Bloos F, Wilson DC, et al. The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis – a secondary analysis of a large randomised controlled trial. Crit Care. 2018;22(1):79. doi: 10.1186/s13054-018-2001-5.
  • Montrucchio G, Sales G, Rumbolo F, et al. Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: an observational prospective study. PLOS One. 2021;16(2):e0246771. doi: 10.1371/journal.pone.0246771.
  • Schmidt T. Coping with copulas. Copulas – from theory to application in finance; 2007.
  • Orden de 17/11/2014, de la Consejería de Sanidad Y Asuntos Sociales. Por la Que se Establecen Los Precios Públicos de la Asistencia Sanitaria Y de los Servicios Prestados en la Red de Centros Sanitarios Dependientes Del Servicio de Salud de Castilla-La Mancha [cited 2023 Feb 2]. Available from: https://noticias.juridicas.com/base_datos/CCAA/539877-orden-sanidad-y-asuntos-sociales-17-nov-2014-ca-castilla-la-mancha-precios.html
  • Potluri R, Ranjan S, Bhandari H, et al. Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma. Exp Hematol Oncol. 2019;8:14. doi: 10.1186/s40164-019-0138-9.
  • OBI Regional Tariffs (Campania ER, FVG, Lazio, Liguria, Bolzano, Veneto) weighted for resident population (ISTAT 2020); 2020 [cited 2023 Feb 2]. Available from: https://www.salute.gov.it/imgs/C_17_pubblicazioni_3142_allegato.pdf
  • National Cost Collection for the NHS [cited 2023 Feb 4]. Available from: https://www.england.nhs.uk/costing-in-the-nhs/national-cost-collection/
  • Mayordomo JI, López A, Viñolas N, et al. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain. Curr Med Res Opin. 2009;25(10):2533–2542. doi: 10.1185/03007990903209563.
  • Kim PJ, Lookess S, Bongards C, et al. Economic model to estimate cost of negative pressure wound therapy with instillation vs control therapies for hospitalised patients in the United States, Germany, and United Kingdom. Int Wound J. 2022;19(4):888–894. doi: 10.1111/iwj.13689.
  • Guest JF, Keating T, Gould D, et al. Modelling the annual NHS costs and outcomes attributable to healthcare-associated infections in England. BMJ Open. 2020;10(1):e033367. doi: 10.1136/bmjopen-2019-033367.
  • AGENAS – Agenzia Nazionale per i Servizi Sanitari [cited 2023 Feb 3]. Available from: https://www.agenas.gov.it/
  • Eurostat – Harmonised Index of Consumer Prices (HICP) [cited 2023 Feb 3]. Available from: https://ec.europa.eu/eurostat/web/hicp
  • ISPOR – The Professional Society for Health Economics and Outcomes Research [cited 2023 May 29]. Available from: https://www.ispor.org/heor-resources/good-practices/article/model-transparency-and-validation